Baidu
map
OPEN LIFE SCI 润色咨询

Open Life Sciences

出版年份：2014 年文章数：455 投稿命中率： 开通期刊会员，数据随心看

出版周期：annual 自引率：0.0% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2201104, encodeId=55ba22011047a, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享：我真服了，投快俩月，一直是投稿状态，巨慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=275d5308532, createdName=14880e46m15(暂无昵称), createdTime=Mon Apr 29 17:29:43 CST 2024, time=2024-04-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2202098, encodeId=3d39220209810, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：请问各位大佬，返修回去后还给会送给原来的审稿人再审吗？，还是 主编或编辑直接决定？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Tue May 07 00:13:15 CST 2024, time=2024-05-07, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1200925, encodeId=462f12009251a, content=Required Reviews Completed一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d89a2575885, createdName=1259293fm78暂无昵称, createdTime=Wed Mar 09 16:15:44 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199506, encodeId=945a2199506ee, content=请问各位友友，Required Reviews Completed是什么状态呀，会不会接着又是拒稿啊，4月10号才分配编辑，没过几天就外审了，4月17号就是Required Reviews Completed，被拒稿拒出阴影了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Sat Apr 20 22:43:16 CST 2024, time=2024-04-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2197397, encodeId=d5d2219e39734, content=3.10投的，4.8了还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Mon Apr 08 15:15:11 CST 2024, time=2024-04-08, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2164982, encodeId=ca952164982e6, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：中医药;组学<br>经验分享：2023.08.17 Submitted<br>2023.08.22 Editor Invited<br>2023.09.01 With Editor<br>2023.09.03 Under Review<br>2023.09.18 Under Review<br>2023.09.21 Under Review<br>2023.09.22 Under Review<br>2023.10.06 Under Review<br>2023.10.10 Decision in Process<br>2023.10.10 Revise<br>2023.10.18 Revised Manuscript Submitted<br>2023.10.19 With Editor<br>2023.10.22 Decision in Process<br>2023.10.23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36a58750083, createdName=ms1000002064329160, createdTime=Thu Oct 26 08:59:24 CST 2023, time=2023-10-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2157145, encodeId=ed20215e145a6, content=6月21投稿，7月13号外审，8月24号外审回来修稿，8月29号修稿后提交，9月4号接收，中间有写过催稿信，感觉编辑都很友好，会回复信件而且也加快进度了，感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202406/80984ecf602246ee81c409daab29bdc7-NEmwDYJZoM0d.jpg, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Mon Sep 11 15:34:48 CST 2023, time=2023-09-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1064223, encodeId=9dda106422349, content=刚发表一篇。4月15号投的，一个月才送review，一审花了快4个月，四个申稿人，两周时间要修回，二审两周给接收意见，两周proof，紧接着online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8b9c5444274, createdName=ms7000001748793110, createdTime=Wed Oct 27 00:14:15 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160003, encodeId=97172160003a8, content=请问各位大佬状态为Editor Declined Invitation是什么意思啊？要拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61555705088, createdName=ms7000000631832992, createdTime=Wed Sep 27 10:19:38 CST 2023, time=2023-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125120, encodeId=f7b72125120e9, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：肝病;肝衰竭;中西医<br>经验分享：22年11月投稿，1修是2月，2修改图片格式等等，4月初录用，19000的版面费，总体来说还可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46868485540, createdName=ms7000001641226377, createdTime=Tue Apr 11 15:53:03 CST 2023, time=2023-04-11, status=1, ipAttribution=广西)]
    2024-04-29 14880e46m15(暂无昵称) 来自河南省

    审稿速度:12.0 | 投稿命中率:5.0
    经验分享：我真服了，投快俩月，一直是投稿状态，巨慢。

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2201104, encodeId=55ba22011047a, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享：我真服了，投快俩月，一直是投稿状态，巨慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=275d5308532, createdName=14880e46m15(暂无昵称), createdTime=Mon Apr 29 17:29:43 CST 2024, time=2024-04-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2202098, encodeId=3d39220209810, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：请问各位大佬，返修回去后还给会送给原来的审稿人再审吗？，还是 主编或编辑直接决定？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Tue May 07 00:13:15 CST 2024, time=2024-05-07, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1200925, encodeId=462f12009251a, content=Required Reviews Completed一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d89a2575885, createdName=1259293fm78暂无昵称, createdTime=Wed Mar 09 16:15:44 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199506, encodeId=945a2199506ee, content=请问各位友友，Required Reviews Completed是什么状态呀，会不会接着又是拒稿啊，4月10号才分配编辑，没过几天就外审了，4月17号就是Required Reviews Completed，被拒稿拒出阴影了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Sat Apr 20 22:43:16 CST 2024, time=2024-04-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2197397, encodeId=d5d2219e39734, content=3.10投的，4.8了还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Mon Apr 08 15:15:11 CST 2024, time=2024-04-08, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2164982, encodeId=ca952164982e6, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：中医药;组学<br>经验分享：2023.08.17 Submitted<br>2023.08.22 Editor Invited<br>2023.09.01 With Editor<br>2023.09.03 Under Review<br>2023.09.18 Under Review<br>2023.09.21 Under Review<br>2023.09.22 Under Review<br>2023.10.06 Under Review<br>2023.10.10 Decision in Process<br>2023.10.10 Revise<br>2023.10.18 Revised Manuscript Submitted<br>2023.10.19 With Editor<br>2023.10.22 Decision in Process<br>2023.10.23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36a58750083, createdName=ms1000002064329160, createdTime=Thu Oct 26 08:59:24 CST 2023, time=2023-10-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2157145, encodeId=ed20215e145a6, content=6月21投稿，7月13号外审，8月24号外审回来修稿，8月29号修稿后提交，9月4号接收，中间有写过催稿信，感觉编辑都很友好，会回复信件而且也加快进度了，感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202406/80984ecf602246ee81c409daab29bdc7-NEmwDYJZoM0d.jpg, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Mon Sep 11 15:34:48 CST 2023, time=2023-09-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1064223, encodeId=9dda106422349, content=刚发表一篇。4月15号投的，一个月才送review，一审花了快4个月，四个申稿人，两周时间要修回，二审两周给接收意见，两周proof，紧接着online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8b9c5444274, createdName=ms7000001748793110, createdTime=Wed Oct 27 00:14:15 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160003, encodeId=97172160003a8, content=请问各位大佬状态为Editor Declined Invitation是什么意思啊？要拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61555705088, createdName=ms7000000631832992, createdTime=Wed Sep 27 10:19:38 CST 2023, time=2023-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125120, encodeId=f7b72125120e9, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：肝病;肝衰竭;中西医<br>经验分享：22年11月投稿，1修是2月，2修改图片格式等等，4月初录用，19000的版面费，总体来说还可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46868485540, createdName=ms7000001641226377, createdTime=Tue Apr 11 15:53:03 CST 2023, time=2023-04-11, status=1, ipAttribution=广西)]
    2024-05-07 ms7000001126545693 来自广西

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享：请问各位大佬，返修回去后还给会送给原来的审稿人再审吗？，还是 主编或编辑直接决定？

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2201104, encodeId=55ba22011047a, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享：我真服了，投快俩月，一直是投稿状态，巨慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=275d5308532, createdName=14880e46m15(暂无昵称), createdTime=Mon Apr 29 17:29:43 CST 2024, time=2024-04-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2202098, encodeId=3d39220209810, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：请问各位大佬，返修回去后还给会送给原来的审稿人再审吗？，还是 主编或编辑直接决定？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Tue May 07 00:13:15 CST 2024, time=2024-05-07, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1200925, encodeId=462f12009251a, content=Required Reviews Completed一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d89a2575885, createdName=1259293fm78暂无昵称, createdTime=Wed Mar 09 16:15:44 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199506, encodeId=945a2199506ee, content=请问各位友友，Required Reviews Completed是什么状态呀，会不会接着又是拒稿啊，4月10号才分配编辑，没过几天就外审了，4月17号就是Required Reviews Completed，被拒稿拒出阴影了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Sat Apr 20 22:43:16 CST 2024, time=2024-04-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2197397, encodeId=d5d2219e39734, content=3.10投的，4.8了还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Mon Apr 08 15:15:11 CST 2024, time=2024-04-08, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2164982, encodeId=ca952164982e6, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：中医药;组学<br>经验分享：2023.08.17 Submitted<br>2023.08.22 Editor Invited<br>2023.09.01 With Editor<br>2023.09.03 Under Review<br>2023.09.18 Under Review<br>2023.09.21 Under Review<br>2023.09.22 Under Review<br>2023.10.06 Under Review<br>2023.10.10 Decision in Process<br>2023.10.10 Revise<br>2023.10.18 Revised Manuscript Submitted<br>2023.10.19 With Editor<br>2023.10.22 Decision in Process<br>2023.10.23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36a58750083, createdName=ms1000002064329160, createdTime=Thu Oct 26 08:59:24 CST 2023, time=2023-10-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2157145, encodeId=ed20215e145a6, content=6月21投稿，7月13号外审，8月24号外审回来修稿，8月29号修稿后提交，9月4号接收，中间有写过催稿信，感觉编辑都很友好，会回复信件而且也加快进度了，感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202406/80984ecf602246ee81c409daab29bdc7-NEmwDYJZoM0d.jpg, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Mon Sep 11 15:34:48 CST 2023, time=2023-09-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1064223, encodeId=9dda106422349, content=刚发表一篇。4月15号投的，一个月才送review，一审花了快4个月，四个申稿人，两周时间要修回，二审两周给接收意见，两周proof，紧接着online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8b9c5444274, createdName=ms7000001748793110, createdTime=Wed Oct 27 00:14:15 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160003, encodeId=97172160003a8, content=请问各位大佬状态为Editor Declined Invitation是什么意思啊？要拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61555705088, createdName=ms7000000631832992, createdTime=Wed Sep 27 10:19:38 CST 2023, time=2023-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125120, encodeId=f7b72125120e9, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：肝病;肝衰竭;中西医<br>经验分享：22年11月投稿，1修是2月，2修改图片格式等等，4月初录用，19000的版面费，总体来说还可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46868485540, createdName=ms7000001641226377, createdTime=Tue Apr 11 15:53:03 CST 2023, time=2023-04-11, status=1, ipAttribution=广西)]
    2022-03-09 1259293fm78暂无昵称

    Required Reviews Completed一般多久啊

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2201104, encodeId=55ba22011047a, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享：我真服了，投快俩月，一直是投稿状态，巨慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=275d5308532, createdName=14880e46m15(暂无昵称), createdTime=Mon Apr 29 17:29:43 CST 2024, time=2024-04-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2202098, encodeId=3d39220209810, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：请问各位大佬，返修回去后还给会送给原来的审稿人再审吗？，还是 主编或编辑直接决定？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Tue May 07 00:13:15 CST 2024, time=2024-05-07, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1200925, encodeId=462f12009251a, content=Required Reviews Completed一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d89a2575885, createdName=1259293fm78暂无昵称, createdTime=Wed Mar 09 16:15:44 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199506, encodeId=945a2199506ee, content=请问各位友友，Required Reviews Completed是什么状态呀，会不会接着又是拒稿啊，4月10号才分配编辑，没过几天就外审了，4月17号就是Required Reviews Completed，被拒稿拒出阴影了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Sat Apr 20 22:43:16 CST 2024, time=2024-04-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2197397, encodeId=d5d2219e39734, content=3.10投的，4.8了还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Mon Apr 08 15:15:11 CST 2024, time=2024-04-08, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2164982, encodeId=ca952164982e6, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：中医药;组学<br>经验分享：2023.08.17 Submitted<br>2023.08.22 Editor Invited<br>2023.09.01 With Editor<br>2023.09.03 Under Review<br>2023.09.18 Under Review<br>2023.09.21 Under Review<br>2023.09.22 Under Review<br>2023.10.06 Under Review<br>2023.10.10 Decision in Process<br>2023.10.10 Revise<br>2023.10.18 Revised Manuscript Submitted<br>2023.10.19 With Editor<br>2023.10.22 Decision in Process<br>2023.10.23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36a58750083, createdName=ms1000002064329160, createdTime=Thu Oct 26 08:59:24 CST 2023, time=2023-10-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2157145, encodeId=ed20215e145a6, content=6月21投稿，7月13号外审，8月24号外审回来修稿，8月29号修稿后提交，9月4号接收，中间有写过催稿信，感觉编辑都很友好，会回复信件而且也加快进度了，感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202406/80984ecf602246ee81c409daab29bdc7-NEmwDYJZoM0d.jpg, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Mon Sep 11 15:34:48 CST 2023, time=2023-09-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1064223, encodeId=9dda106422349, content=刚发表一篇。4月15号投的，一个月才送review，一审花了快4个月，四个申稿人，两周时间要修回，二审两周给接收意见，两周proof，紧接着online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8b9c5444274, createdName=ms7000001748793110, createdTime=Wed Oct 27 00:14:15 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160003, encodeId=97172160003a8, content=请问各位大佬状态为Editor Declined Invitation是什么意思啊？要拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61555705088, createdName=ms7000000631832992, createdTime=Wed Sep 27 10:19:38 CST 2023, time=2023-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125120, encodeId=f7b72125120e9, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：肝病;肝衰竭;中西医<br>经验分享：22年11月投稿，1修是2月，2修改图片格式等等，4月初录用，19000的版面费，总体来说还可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46868485540, createdName=ms7000001641226377, createdTime=Tue Apr 11 15:53:03 CST 2023, time=2023-04-11, status=1, ipAttribution=广西)]
    2024-04-20 ms7000001126545693 来自广西

    请问各位友友，Required Reviews Completed是什么状态呀，会不会接着又是拒稿啊，4月10号才分配编辑，没过几天就外审了，4月17号就是Required Reviews Completed，被拒稿拒出阴影了。。。

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2201104, encodeId=55ba22011047a, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享：我真服了，投快俩月，一直是投稿状态，巨慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=275d5308532, createdName=14880e46m15(暂无昵称), createdTime=Mon Apr 29 17:29:43 CST 2024, time=2024-04-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2202098, encodeId=3d39220209810, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：请问各位大佬，返修回去后还给会送给原来的审稿人再审吗？，还是 主编或编辑直接决定？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Tue May 07 00:13:15 CST 2024, time=2024-05-07, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1200925, encodeId=462f12009251a, content=Required Reviews Completed一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d89a2575885, createdName=1259293fm78暂无昵称, createdTime=Wed Mar 09 16:15:44 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199506, encodeId=945a2199506ee, content=请问各位友友，Required Reviews Completed是什么状态呀，会不会接着又是拒稿啊，4月10号才分配编辑，没过几天就外审了，4月17号就是Required Reviews Completed，被拒稿拒出阴影了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Sat Apr 20 22:43:16 CST 2024, time=2024-04-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2197397, encodeId=d5d2219e39734, content=3.10投的，4.8了还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Mon Apr 08 15:15:11 CST 2024, time=2024-04-08, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2164982, encodeId=ca952164982e6, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：中医药;组学<br>经验分享：2023.08.17 Submitted<br>2023.08.22 Editor Invited<br>2023.09.01 With Editor<br>2023.09.03 Under Review<br>2023.09.18 Under Review<br>2023.09.21 Under Review<br>2023.09.22 Under Review<br>2023.10.06 Under Review<br>2023.10.10 Decision in Process<br>2023.10.10 Revise<br>2023.10.18 Revised Manuscript Submitted<br>2023.10.19 With Editor<br>2023.10.22 Decision in Process<br>2023.10.23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36a58750083, createdName=ms1000002064329160, createdTime=Thu Oct 26 08:59:24 CST 2023, time=2023-10-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2157145, encodeId=ed20215e145a6, content=6月21投稿，7月13号外审，8月24号外审回来修稿，8月29号修稿后提交，9月4号接收，中间有写过催稿信，感觉编辑都很友好，会回复信件而且也加快进度了，感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202406/80984ecf602246ee81c409daab29bdc7-NEmwDYJZoM0d.jpg, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Mon Sep 11 15:34:48 CST 2023, time=2023-09-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1064223, encodeId=9dda106422349, content=刚发表一篇。4月15号投的，一个月才送review，一审花了快4个月，四个申稿人，两周时间要修回，二审两周给接收意见，两周proof，紧接着online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8b9c5444274, createdName=ms7000001748793110, createdTime=Wed Oct 27 00:14:15 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160003, encodeId=97172160003a8, content=请问各位大佬状态为Editor Declined Invitation是什么意思啊？要拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61555705088, createdName=ms7000000631832992, createdTime=Wed Sep 27 10:19:38 CST 2023, time=2023-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125120, encodeId=f7b72125120e9, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：肝病;肝衰竭;中西医<br>经验分享：22年11月投稿，1修是2月，2修改图片格式等等，4月初录用，19000的版面费，总体来说还可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46868485540, createdName=ms7000001641226377, createdTime=Tue Apr 11 15:53:03 CST 2023, time=2023-04-11, status=1, ipAttribution=广西)]
    2024-04-08 ms7000001126545693 来自广西

    3.10投的，4.8了还没分配编辑

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2201104, encodeId=55ba22011047a, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享：我真服了，投快俩月，一直是投稿状态，巨慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=275d5308532, createdName=14880e46m15(暂无昵称), createdTime=Mon Apr 29 17:29:43 CST 2024, time=2024-04-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2202098, encodeId=3d39220209810, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：请问各位大佬，返修回去后还给会送给原来的审稿人再审吗？，还是 主编或编辑直接决定？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Tue May 07 00:13:15 CST 2024, time=2024-05-07, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1200925, encodeId=462f12009251a, content=Required Reviews Completed一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d89a2575885, createdName=1259293fm78暂无昵称, createdTime=Wed Mar 09 16:15:44 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199506, encodeId=945a2199506ee, content=请问各位友友，Required Reviews Completed是什么状态呀，会不会接着又是拒稿啊，4月10号才分配编辑，没过几天就外审了，4月17号就是Required Reviews Completed，被拒稿拒出阴影了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Sat Apr 20 22:43:16 CST 2024, time=2024-04-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2197397, encodeId=d5d2219e39734, content=3.10投的，4.8了还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Mon Apr 08 15:15:11 CST 2024, time=2024-04-08, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2164982, encodeId=ca952164982e6, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：中医药;组学<br>经验分享：2023.08.17 Submitted<br>2023.08.22 Editor Invited<br>2023.09.01 With Editor<br>2023.09.03 Under Review<br>2023.09.18 Under Review<br>2023.09.21 Under Review<br>2023.09.22 Under Review<br>2023.10.06 Under Review<br>2023.10.10 Decision in Process<br>2023.10.10 Revise<br>2023.10.18 Revised Manuscript Submitted<br>2023.10.19 With Editor<br>2023.10.22 Decision in Process<br>2023.10.23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36a58750083, createdName=ms1000002064329160, createdTime=Thu Oct 26 08:59:24 CST 2023, time=2023-10-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2157145, encodeId=ed20215e145a6, content=6月21投稿，7月13号外审，8月24号外审回来修稿，8月29号修稿后提交，9月4号接收，中间有写过催稿信，感觉编辑都很友好，会回复信件而且也加快进度了，感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202406/80984ecf602246ee81c409daab29bdc7-NEmwDYJZoM0d.jpg, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Mon Sep 11 15:34:48 CST 2023, time=2023-09-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1064223, encodeId=9dda106422349, content=刚发表一篇。4月15号投的，一个月才送review，一审花了快4个月，四个申稿人，两周时间要修回，二审两周给接收意见，两周proof，紧接着online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8b9c5444274, createdName=ms7000001748793110, createdTime=Wed Oct 27 00:14:15 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160003, encodeId=97172160003a8, content=请问各位大佬状态为Editor Declined Invitation是什么意思啊？要拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61555705088, createdName=ms7000000631832992, createdTime=Wed Sep 27 10:19:38 CST 2023, time=2023-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125120, encodeId=f7b72125120e9, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：肝病;肝衰竭;中西医<br>经验分享：22年11月投稿，1修是2月，2修改图片格式等等，4月初录用，19000的版面费，总体来说还可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46868485540, createdName=ms7000001641226377, createdTime=Tue Apr 11 15:53:03 CST 2023, time=2023-04-11, status=1, ipAttribution=广西)]
    2023-10-26 ms1000002064329160 来自江苏省

    审稿速度:2.0 | 投稿命中率:75.0
    偏重的研究方向：中医药;组学
    经验分享：2023.08.17 Submitted
    2023.08.22 Editor Invited
    2023.09.01 With Editor
    2023.09.03 Under Review
    2023.09.18 Under Review
    2023.09.21 Under Review
    2023.09.22 Under Review
    2023.10.06 Under Review
    2023.10.10 Decision in Process
    2023.10.10 Revise
    2023.10.18 Revised Manuscript Submitted
    2023.10.19 With Editor
    2023.10.22 Decision in Process
    2023.10.23 Accept

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2201104, encodeId=55ba22011047a, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享：我真服了，投快俩月，一直是投稿状态，巨慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=275d5308532, createdName=14880e46m15(暂无昵称), createdTime=Mon Apr 29 17:29:43 CST 2024, time=2024-04-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2202098, encodeId=3d39220209810, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：请问各位大佬，返修回去后还给会送给原来的审稿人再审吗？，还是 主编或编辑直接决定？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Tue May 07 00:13:15 CST 2024, time=2024-05-07, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1200925, encodeId=462f12009251a, content=Required Reviews Completed一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d89a2575885, createdName=1259293fm78暂无昵称, createdTime=Wed Mar 09 16:15:44 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199506, encodeId=945a2199506ee, content=请问各位友友，Required Reviews Completed是什么状态呀，会不会接着又是拒稿啊，4月10号才分配编辑，没过几天就外审了，4月17号就是Required Reviews Completed，被拒稿拒出阴影了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Sat Apr 20 22:43:16 CST 2024, time=2024-04-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2197397, encodeId=d5d2219e39734, content=3.10投的，4.8了还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Mon Apr 08 15:15:11 CST 2024, time=2024-04-08, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2164982, encodeId=ca952164982e6, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：中医药;组学<br>经验分享：2023.08.17 Submitted<br>2023.08.22 Editor Invited<br>2023.09.01 With Editor<br>2023.09.03 Under Review<br>2023.09.18 Under Review<br>2023.09.21 Under Review<br>2023.09.22 Under Review<br>2023.10.06 Under Review<br>2023.10.10 Decision in Process<br>2023.10.10 Revise<br>2023.10.18 Revised Manuscript Submitted<br>2023.10.19 With Editor<br>2023.10.22 Decision in Process<br>2023.10.23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36a58750083, createdName=ms1000002064329160, createdTime=Thu Oct 26 08:59:24 CST 2023, time=2023-10-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2157145, encodeId=ed20215e145a6, content=6月21投稿，7月13号外审，8月24号外审回来修稿，8月29号修稿后提交，9月4号接收，中间有写过催稿信，感觉编辑都很友好，会回复信件而且也加快进度了，感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202406/80984ecf602246ee81c409daab29bdc7-NEmwDYJZoM0d.jpg, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Mon Sep 11 15:34:48 CST 2023, time=2023-09-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1064223, encodeId=9dda106422349, content=刚发表一篇。4月15号投的，一个月才送review，一审花了快4个月，四个申稿人，两周时间要修回，二审两周给接收意见，两周proof，紧接着online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8b9c5444274, createdName=ms7000001748793110, createdTime=Wed Oct 27 00:14:15 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160003, encodeId=97172160003a8, content=请问各位大佬状态为Editor Declined Invitation是什么意思啊？要拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61555705088, createdName=ms7000000631832992, createdTime=Wed Sep 27 10:19:38 CST 2023, time=2023-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125120, encodeId=f7b72125120e9, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：肝病;肝衰竭;中西医<br>经验分享：22年11月投稿，1修是2月，2修改图片格式等等，4月初录用，19000的版面费，总体来说还可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46868485540, createdName=ms7000001641226377, createdTime=Tue Apr 11 15:53:03 CST 2023, time=2023-04-11, status=1, ipAttribution=广西)]
    2023-09-11 156GRoK0535(apple) 来自福建省

    6月21投稿，7月13号外审，8月24号外审回来修稿，8月29号修稿后提交，9月4号接收，中间有写过催稿信，感觉编辑都很友好，会回复信件而且也加快进度了，感谢！

    8

    展开8条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2201104, encodeId=55ba22011047a, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享：我真服了，投快俩月，一直是投稿状态，巨慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=275d5308532, createdName=14880e46m15(暂无昵称), createdTime=Mon Apr 29 17:29:43 CST 2024, time=2024-04-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2202098, encodeId=3d39220209810, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：请问各位大佬，返修回去后还给会送给原来的审稿人再审吗？，还是 主编或编辑直接决定？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Tue May 07 00:13:15 CST 2024, time=2024-05-07, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1200925, encodeId=462f12009251a, content=Required Reviews Completed一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d89a2575885, createdName=1259293fm78暂无昵称, createdTime=Wed Mar 09 16:15:44 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199506, encodeId=945a2199506ee, content=请问各位友友，Required Reviews Completed是什么状态呀，会不会接着又是拒稿啊，4月10号才分配编辑，没过几天就外审了，4月17号就是Required Reviews Completed，被拒稿拒出阴影了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Sat Apr 20 22:43:16 CST 2024, time=2024-04-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2197397, encodeId=d5d2219e39734, content=3.10投的，4.8了还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Mon Apr 08 15:15:11 CST 2024, time=2024-04-08, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2164982, encodeId=ca952164982e6, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：中医药;组学<br>经验分享：2023.08.17 Submitted<br>2023.08.22 Editor Invited<br>2023.09.01 With Editor<br>2023.09.03 Under Review<br>2023.09.18 Under Review<br>2023.09.21 Under Review<br>2023.09.22 Under Review<br>2023.10.06 Under Review<br>2023.10.10 Decision in Process<br>2023.10.10 Revise<br>2023.10.18 Revised Manuscript Submitted<br>2023.10.19 With Editor<br>2023.10.22 Decision in Process<br>2023.10.23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36a58750083, createdName=ms1000002064329160, createdTime=Thu Oct 26 08:59:24 CST 2023, time=2023-10-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2157145, encodeId=ed20215e145a6, content=6月21投稿，7月13号外审，8月24号外审回来修稿，8月29号修稿后提交，9月4号接收，中间有写过催稿信，感觉编辑都很友好，会回复信件而且也加快进度了，感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202406/80984ecf602246ee81c409daab29bdc7-NEmwDYJZoM0d.jpg, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Mon Sep 11 15:34:48 CST 2023, time=2023-09-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1064223, encodeId=9dda106422349, content=刚发表一篇。4月15号投的，一个月才送review，一审花了快4个月，四个申稿人，两周时间要修回，二审两周给接收意见，两周proof，紧接着online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8b9c5444274, createdName=ms7000001748793110, createdTime=Wed Oct 27 00:14:15 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160003, encodeId=97172160003a8, content=请问各位大佬状态为Editor Declined Invitation是什么意思啊？要拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61555705088, createdName=ms7000000631832992, createdTime=Wed Sep 27 10:19:38 CST 2023, time=2023-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125120, encodeId=f7b72125120e9, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：肝病;肝衰竭;中西医<br>经验分享：22年11月投稿，1修是2月，2修改图片格式等等，4月初录用，19000的版面费，总体来说还可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46868485540, createdName=ms7000001641226377, createdTime=Tue Apr 11 15:53:03 CST 2023, time=2023-04-11, status=1, ipAttribution=广西)]
    2021-10-27 ms7000001748793110

    刚发表一篇。4月15号投的，一个月才送review，一审花了快4个月，四个申稿人，两周时间要修回，二审两周给接收意见，两周proof，紧接着online。

    8

    展开8条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2201104, encodeId=55ba22011047a, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享：我真服了，投快俩月，一直是投稿状态，巨慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=275d5308532, createdName=14880e46m15(暂无昵称), createdTime=Mon Apr 29 17:29:43 CST 2024, time=2024-04-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2202098, encodeId=3d39220209810, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：请问各位大佬，返修回去后还给会送给原来的审稿人再审吗？，还是 主编或编辑直接决定？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Tue May 07 00:13:15 CST 2024, time=2024-05-07, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1200925, encodeId=462f12009251a, content=Required Reviews Completed一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d89a2575885, createdName=1259293fm78暂无昵称, createdTime=Wed Mar 09 16:15:44 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199506, encodeId=945a2199506ee, content=请问各位友友，Required Reviews Completed是什么状态呀，会不会接着又是拒稿啊，4月10号才分配编辑，没过几天就外审了，4月17号就是Required Reviews Completed，被拒稿拒出阴影了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Sat Apr 20 22:43:16 CST 2024, time=2024-04-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2197397, encodeId=d5d2219e39734, content=3.10投的，4.8了还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Mon Apr 08 15:15:11 CST 2024, time=2024-04-08, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2164982, encodeId=ca952164982e6, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：中医药;组学<br>经验分享：2023.08.17 Submitted<br>2023.08.22 Editor Invited<br>2023.09.01 With Editor<br>2023.09.03 Under Review<br>2023.09.18 Under Review<br>2023.09.21 Under Review<br>2023.09.22 Under Review<br>2023.10.06 Under Review<br>2023.10.10 Decision in Process<br>2023.10.10 Revise<br>2023.10.18 Revised Manuscript Submitted<br>2023.10.19 With Editor<br>2023.10.22 Decision in Process<br>2023.10.23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36a58750083, createdName=ms1000002064329160, createdTime=Thu Oct 26 08:59:24 CST 2023, time=2023-10-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2157145, encodeId=ed20215e145a6, content=6月21投稿，7月13号外审，8月24号外审回来修稿，8月29号修稿后提交，9月4号接收，中间有写过催稿信，感觉编辑都很友好，会回复信件而且也加快进度了，感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202406/80984ecf602246ee81c409daab29bdc7-NEmwDYJZoM0d.jpg, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Mon Sep 11 15:34:48 CST 2023, time=2023-09-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1064223, encodeId=9dda106422349, content=刚发表一篇。4月15号投的，一个月才送review，一审花了快4个月，四个申稿人，两周时间要修回，二审两周给接收意见，两周proof，紧接着online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8b9c5444274, createdName=ms7000001748793110, createdTime=Wed Oct 27 00:14:15 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160003, encodeId=97172160003a8, content=请问各位大佬状态为Editor Declined Invitation是什么意思啊？要拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61555705088, createdName=ms7000000631832992, createdTime=Wed Sep 27 10:19:38 CST 2023, time=2023-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125120, encodeId=f7b72125120e9, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：肝病;肝衰竭;中西医<br>经验分享：22年11月投稿，1修是2月，2修改图片格式等等，4月初录用，19000的版面费，总体来说还可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46868485540, createdName=ms7000001641226377, createdTime=Tue Apr 11 15:53:03 CST 2023, time=2023-04-11, status=1, ipAttribution=广西)]
    2023-09-27 ms7000000631832992

    请问各位大佬状态为Editor Declined Invitation是什么意思啊？要拒稿了吗？

    2

    展开2条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2201104, encodeId=55ba22011047a, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享：我真服了，投快俩月，一直是投稿状态，巨慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=275d5308532, createdName=14880e46m15(暂无昵称), createdTime=Mon Apr 29 17:29:43 CST 2024, time=2024-04-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2202098, encodeId=3d39220209810, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：请问各位大佬，返修回去后还给会送给原来的审稿人再审吗？，还是 主编或编辑直接决定？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Tue May 07 00:13:15 CST 2024, time=2024-05-07, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1200925, encodeId=462f12009251a, content=Required Reviews Completed一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d89a2575885, createdName=1259293fm78暂无昵称, createdTime=Wed Mar 09 16:15:44 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199506, encodeId=945a2199506ee, content=请问各位友友，Required Reviews Completed是什么状态呀，会不会接着又是拒稿啊，4月10号才分配编辑，没过几天就外审了，4月17号就是Required Reviews Completed，被拒稿拒出阴影了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Sat Apr 20 22:43:16 CST 2024, time=2024-04-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2197397, encodeId=d5d2219e39734, content=3.10投的，4.8了还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Mon Apr 08 15:15:11 CST 2024, time=2024-04-08, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2164982, encodeId=ca952164982e6, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：中医药;组学<br>经验分享：2023.08.17 Submitted<br>2023.08.22 Editor Invited<br>2023.09.01 With Editor<br>2023.09.03 Under Review<br>2023.09.18 Under Review<br>2023.09.21 Under Review<br>2023.09.22 Under Review<br>2023.10.06 Under Review<br>2023.10.10 Decision in Process<br>2023.10.10 Revise<br>2023.10.18 Revised Manuscript Submitted<br>2023.10.19 With Editor<br>2023.10.22 Decision in Process<br>2023.10.23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36a58750083, createdName=ms1000002064329160, createdTime=Thu Oct 26 08:59:24 CST 2023, time=2023-10-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2157145, encodeId=ed20215e145a6, content=6月21投稿，7月13号外审，8月24号外审回来修稿，8月29号修稿后提交，9月4号接收，中间有写过催稿信，感觉编辑都很友好，会回复信件而且也加快进度了，感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202406/80984ecf602246ee81c409daab29bdc7-NEmwDYJZoM0d.jpg, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Mon Sep 11 15:34:48 CST 2023, time=2023-09-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1064223, encodeId=9dda106422349, content=刚发表一篇。4月15号投的，一个月才送review，一审花了快4个月，四个申稿人，两周时间要修回，二审两周给接收意见，两周proof，紧接着online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8b9c5444274, createdName=ms7000001748793110, createdTime=Wed Oct 27 00:14:15 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160003, encodeId=97172160003a8, content=请问各位大佬状态为Editor Declined Invitation是什么意思啊？要拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61555705088, createdName=ms7000000631832992, createdTime=Wed Sep 27 10:19:38 CST 2023, time=2023-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125120, encodeId=f7b72125120e9, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：肝病;肝衰竭;中西医<br>经验分享：22年11月投稿，1修是2月，2修改图片格式等等，4月初录用，19000的版面费，总体来说还可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46868485540, createdName=ms7000001641226377, createdTime=Tue Apr 11 15:53:03 CST 2023, time=2023-04-11, status=1, ipAttribution=广西)]
    2023-04-11 ms7000001641226377 来自广西

    审稿速度:6.0 | 投稿命中率:75.0
    偏重的研究方向：肝病;肝衰竭;中西医
    经验分享：22年11月投稿，1修是2月，2修改图片格式等等，4月初录用，19000的版面费，总体来说还可以

    3

    展开3条回复
共85条页码: 1/9页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map